Financial Data and Key Metrics Changes - Marina Bay Sands achieved an EBITDA of $806 million, marking the highest quarter in the history of casino hotels, with a total EBITDA exceeding $2.9 billion for the year [4] - Macau delivered an EBITDA of $608 million for the quarter, with an adjusted EBITDA margin of 28.9%, down 390 basis points compared to Q4 2024 [6][8] - The company repurchased $500 million of LVS stock during the quarter and paid a recurring quarterly dividend of $0.25 per share [7] Business Line Data and Key Metrics Changes - Mass gaming in Singapore reached $951 million for the quarter, up 118% from Q4 2019 and up 27% from Q4 last year [4] - Macau's mass market revenue exceeded 25% share for the quarter, up 23.6% in the first quarter of 2025 [5] - The Venetian's EBITDA margin was 32.3%, while The Londoner's margin was 28.8% [6] Market Data and Key Metrics Changes - The Macau market is currently driven by the premium segment, with a focus on rolling and non-rolling segments [5][6] - The promotional environment in Macau has become more intense, particularly in the premium segments [31] Company Strategy and Development Direction - The company is focused on maximizing asset performance and achieving $700 million per quarter in Macau [5] - Continued investment in Singapore and renovations to enhance service offerings are planned [16] - The company is exploring new development opportunities in markets like Japan but is currently focused on existing properties [60] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth trajectory in both Singapore and Macau, citing strong customer demand and market positioning [24][46] - The company acknowledged challenges in the base mass segment but remains committed to improving revenue and EBITDA [97] - Management emphasized the unpredictability of future performance but noted a strong belief in the potential for continued growth [46] Other Important Information - The company increased its ownership percentage of SCL to 74.8% as of December 31, 2025 [9] - The impact of the NBA events in Macau was noted as a significant success, contributing to brand projection and stakeholder engagement [70] Q&A Session Summary Question: What is driving the strong quarter in Singapore? - Management attributed the success to the property's offerings and an increase in customer visits, with no significant changes needed in operations [14][16] Question: What is the outlook for Macau's EBITDA recovery? - Management indicated that they are focused on customer growth and revenue, with a positive trajectory expected despite current margin pressures [22][24] Question: How is the promotional environment in Macau evolving? - The promotional environment remains intense, particularly in premium segments, but management sees stabilization in promotional intensity [31][32] Question: Are there any concerns about the World Cup affecting traffic? - Management believes the World Cup will not significantly impact traffic, as customers can engage with the event remotely [55] Question: What is the strategy for the base mass segment? - Management noted that while visitation remains strong, spend per head in the base mass segment has declined, and they are working on initiatives to stimulate higher spending [102]

Financial Data and Key Metrics Changes - Total sales for Q4 2025 were $373.2 million, a year-over-year increase of 7.9% as reported and 7.1% in constant currency [5] - For the full year, sales were $1.375 billion, representing year-over-year growth of 5.2% as reported and 5.1% in constant currency [5] - Adjusted earnings per share for Q4 were $1.43, growing 6.7%, while full-year adjusted EPS was $4.59, growing 10.1% [5][21] - GAAP net income for Q4 was $16.7 million, down from $33.8 million in Q4 2024, with GAAP earnings per diluted share at $0.54 compared to $1.08 a year ago [19] Business Line Data and Key Metrics Changes - Orthopedic sales increased 12.1% in Q4 and 5.5% for the full year on a constant currency basis [5] - General surgery sales increased 3.8% in Q4 and 4.7% for the full year in constant currency [5] - U.S. orthopedic sales grew 6.6% in Q4, while international orthopedic sales increased 15.7% [16] - U.S. general surgery sales declined 0.4%, while international general surgery sales increased 14.8% [16] Market Data and Key Metrics Changes - International sales grew 15.4% in Q4, while U.S. sales increased 1.4% [15] - The decline in U.S. general surgery was attributed to a focus on non-core areas and strategic portfolio management [16] Company Strategy and Development Direction - The company plans to exit its gastroenterology product lines to focus on high-growth, high-margin markets such as robotic and laparoscopic surgery [6][7] - The strategy includes stabilizing and scaling operations to build a high-performance supply chain [8] - The company aims to deliver sustained above-market growth in its orthopedic portfolio over time [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to return to above-market growth by focusing on core strengths and investing in high-growth platforms [13] - The company is optimistic about the long-term growth potential of its AirSeal and BioBrace products, with expectations of high single-digit to low double-digit growth rates [10][12] Other Important Information - The company suspended its dividend and approved a $150 million share repurchase authorization [12] - The leverage ratio at the end of the year was 2.9 times, providing flexibility for innovation and growth [12] Q&A Session Summary Question: Can you talk about the cadence for the rest of the year and any selling day differences? - Management indicated no selling day differences and expected normal seasonality for the med tech calendar [30] Question: What is the status of the CFO search? - The company is actively searching for a new CFO who will focus on shareholder value and be a strong teammate to the leadership team [32] Question: Can you clarify the organic revenue numbers presented at the healthcare conference versus today? - The difference was due to final numbers rolling out, with the current guidance being more precise [35] Question: What drove the upside in orthopedic sales and the downside in general surgery? - The orthopedic sales beat was attributed to committed sales professionals, improving supply chain, and new product approvals, while general surgery faced challenges due to portfolio management [37][40] Question: How will the GI business be reported going forward? - The GI business will be reported separately as the company moves forward [54]

Q4 2025 Earnings Presentation 2024 INVESTOR DAY January 28, 2026 Safe Harbor Statement Except for the historical information contained herein, the matters set forth in this release are forward-looking statements that represent our expectations, beliefs, intentions or strategies concerning future events. These forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from our historical experience or our present expectations, including, but ...

Financial Data and Key Metrics Changes - Net revenue for Q2 2026 was $369.3 million, up 23.5% sequentially and 36.4% year-over-year, exceeding guidance of $360-$370 million [4] - Operating margin for Q2 was 19.3%, above the guidance range of 17.3%-18.5%, and increased by 360 basis points quarter-over-quarter and 440 basis points year-over-year [4] - EPS was $0.22, above the guidance range of $0.18-$0.20, and increased by $0.07 sequentially and $0.09 year-over-year [5] Business Segment Data and Key Metrics Changes - NSE revenue for Q2 was $291.5 million, up 45.8% year-over-year, driven by acquisitions and strong demand in the data center ecosystem [5][6] - OSP revenue for Q2 was $77.8 million, up 9.7% year-over-year, primarily due to strength in anti-counterfeiting products [6][7] - NSE gross margin was 64.7%, slightly down year-over-year, while OSP gross margin was 50.8%, up 20 basis points year-over-year [6][7] Market Data and Key Metrics Changes - Strong demand was noted in the data center ecosystem, particularly for lab and production products, driven by AI data center build-outs [15] - Aerospace and defense business saw significant growth, with continued high demand for positioning, navigation, and timing products [15][16] - Service provider business remained stable, with some opportunistic demand from cable operators transitioning to new architectures [16] Company Strategy and Development Direction - The company approved a restructuring plan affecting approximately 5% of the global workforce, expecting to incur about $32 million in charges but aiming for annual savings of $30 million [10][11] - The focus will be on reinvesting savings into higher growth areas, particularly in data center and aerospace and defense sectors [11][30] - The company anticipates continued revenue momentum in the data center ecosystem through 2026, supported by robust bookings [15][17] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in the ongoing strength of the data center ecosystem and aerospace and defense markets, expecting these trends to continue [15][17] - The company noted improved visibility on demand, with multi-quarter commitments from major customers [26] - Management highlighted the importance of operational efficiency and resource allocation to support growth in strategic areas [30] Other Important Information - Total cash and short-term investments at the end of Q2 were $772.1 million, up from $549.1 million in Q1 [8] - The company did not repurchase any shares during the quarter, prioritizing debt management [10] - The fully diluted share count increased to 233.4 million shares from 224.8 million shares year-over-year [10] Q&A Session Summary Question: Update on NSE business mix across data center, aerospace and defense, and telco - Management indicated a shift towards 45% data center, 40% service provider, and 15% aerospace and defense, reflecting strong growth in data center demand [21][22] Question: Visibility on demand and order backlog - Management confirmed improved visibility on demand, with commitments extending up to three quarters ahead [26] Question: Impact of restructuring on specific product areas - The restructuring is aimed at improving efficiency across multiple functions, not targeting specific areas [29] Question: Exciting defense and aerospace programs - Management highlighted resilient PNT (position, navigation, timing) as a key driver, particularly for drones and autonomous systems [36] Question: Growth in optical domain and data center demand - Management noted strong growth across all segments, particularly driven by advancements in optical technology and increased demand for fiber monitoring [41][45] Question: Breakdown of data center business across lab, production, and field - Management stated that while they do not break down these categories, production is expected to be a significant growth driver linked to volume demands [56][58]

Q4 and FY 2025 Update 1 Highlights 03 Financial Summary 04 Operational Summary 06 Manufacturing & Hardware 08 Supporting Infrastructure 09 AI & Software 10 Services 11 Other Updates 12 Outlook 13 Photos & Charts 14 Key Metrics 24 Financial Statements 27 Additional Information 34 (1) Excludes SBC (stock-based compensation) & Digital assets gains and losses, net of tax; (2) Free cash flow = operating cash flow less capex; (3) Includes cash, cash equivalents and investments; (4)Active driver supervision requir ...

| Microsoft Second Quarter Fiscal Year 2026 Results Microsoft 2 Financial Summary and Highlights Commercial Highlights Agenda Segment Overview and Highlights Appendix All growth comparisons in this presentation relate to the corresponding period of last fiscal year unless otherwise noted. Numbers may not foot due to rounding FY26 Q2 Financial Summary | | | GAAP and CC results | | | Non-GAAP and CC results | | | --- | --- | --- | --- | --- | --- | --- | | ($ in billions, except per share amounts) | FY26 Q2 | ...

Canadian Pacific Kansas City (NYSE:CP) Q4 2025 Earnings call January 28, 2026 04:30 PM ET Speaker12Good afternoon. My name is Angela, and I will be your conference operator today. At this time, I would like to welcome everyone to CPKC's fourth quarter and full year 2025 conference call. The slides accompanying today's call are available at investor.cp kc.com. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you w ...

Summary of Gorilla Technology Group Conference Call Company Overview - **Company**: Gorilla Technology Group (NasdaqCM: GRRR) - **Date of Call**: January 28, 2026 - **Speakers**: Jay Chandan (Chairman and CEO), Bruce Bauer (CFO) Key Points Financial Performance and Projections - **Backlog**: The company has a signed backlog exceeding **$100 million**, which is tied to delivery milestones and represents contracted revenue [4][7] - **Revenue Guidance for 2026**: Expected revenue is projected to be between **$137 million and $200 million**, driven by backlog and ramp-up in data center programs across Asia, the Middle East, and Europe [5][7] - **Data Center Deployment**: Targeting deployment of up to **100 megawatts** by the end of 2026, with plans for several hundred megawatts in subsequent years [6][7] Market Opportunities - **Pipeline**: Actively pursuing deals exceeding **$10 billion** in AI infrastructure and data centers [5][7] - **U.S. Acquisition**: The company is in the process of a U.S. acquisition, which has been delayed due to government shutdowns affecting procurement and approvals [12][13] - **Client Contracts**: A significant contract worth **$1.4 billion** is in place, with the contractor based in Singapore, focusing on AI data center backbone work [15][16] Technology and Infrastructure - **AI Data Center Development**: The company is focusing on building AI reasoning workloads and deploying advanced GPU systems, including the **B300 Grace Blackwell** architecture [16][17] - **Strategic Partnerships**: Collaborating with major partners like NVIDIA, Broadcom, and HPE to enhance delivery capabilities globally [13][14] Financial Strategy - **Project Financing**: Emphasis on non-dilutive project-level capital to maintain corporate cash discipline [19][22] - **Buyback Program**: Increased buyback authorization to **$20 million**, with over **$11 million** already repurchased [35][38] Market Dynamics - **Rising Costs**: Anticipated increases in NVIDIA product prices (60%-70% for DRAM, 20%-40% for HBM3e) are expected to impact gross margins, but the company has structured contracts to manage these costs effectively [27][29] - **Demand Trends**: Increased urgency from clients to secure allocations as prices rise, indicating strong demand for compute resources [30][31] Regional Focus - **India and Southeast Asia**: The AI data center market in India is projected to grow from **$1.9 billion to $4 billion** in the coming years, with significant infrastructure expansion [32][33] - **Global Expansion**: The company is also exploring opportunities in the Middle East, including Saudi Arabia and the UAE, while maintaining operations in Egypt [51][56] Compliance and Governance - **Regulatory Compliance**: Commitment to transparency and compliance with SEC reporting obligations, ensuring accurate disclosures [26][46] R&D and Product Development - **Video Analytics and SDK**: The company has an existing SDK for video analytics and is actively developing integrated solutions for smart city applications [60][61] Conclusion - Gorilla Technology Group is positioned for significant growth in the AI infrastructure and data center market, with a strong backlog, strategic partnerships, and a disciplined financial approach. The company is navigating challenges in the market while focusing on execution and compliance.

Agenus (NasdaqCM:AGEN) Update / briefing January 28, 2026 04:00 PM ET Speaker4Good afternoon, everyone, and thank you for joining us today. I'm Stefanie Perna-Nacar, Chief Communications Officer at Agenus, and welcome to our first stakeholder webcast of 2026. Today's discussion comes at a meaningful moment for our company, one shaped by important progress across patient access, clinical development, and operational readiness as we enter a pivotal year for Agenus and for the patients we serve. Before we begi ...

4Q 2025 Earnings January 28, 2026 ibm.com/investor Forward-looking statements and non-GAAP information Certain comments made in this presentation may be characterized as forward looking under the Private Securities Litigation Reform Act of 1995. Forward- looking statements are based on the company's current assumptions regarding future business and financial performance. Those statements by their nature address matters that are uncertain to different degrees. Those statements involve a number of factors tha ...